Haematology Research Review, Issue 143
In this issue:
SCT using an anti-CD117 antibody in Fanconi anaemia
Dose-optimised recombinant human TPO vs. eltrombopag for ITP
Anti-CD38 monoclonal antibody (CM313) for primary ITP
RGI-2001 for acute GVHD prophylaxis after allogeneic SCT
Elranatamab for relapsed/refractory AL amyloidosis
Venetoclax monotherapy for Waldenström macroglobulinaemia: long-term follow-up
Clinically significant EVH in PNH treated with ravulizumab or eculizumab
Pirfenidone for chronic GVHD-related bronchiolitis obliterans syndrome
Post-SCT DLIs for preventing acute myeloid leukaemia/myelodysplastic syndrome haematological relapse
Allogeneic SCT for relapsed/refractory B-cell non-Hodgkin lymphoma: long-term outcomes
Expert contributor
Professor Jeff Szer
Professor Jeff Szer AM (@marrow), is a member of the Clinical Haematology team at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital. He is also Director of the Western and Central Melbourne Integrated Cancer Service and outgoing President of the World Marrow Donor Association. He established the first adult bone marrow transplant centre in […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.